An inhalational anaesthetic is a chemical compound possessing general anaesthetic properties that can be delivered via inhalation.
This report contains market size and forecasts of Inhalational Anesthesia Drugs in global, including the following market information:
- Global Inhalational Anesthesia Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
- Global Inhalational Anesthesia Drugs Market Sales, 2017-2022, 2023-2028, (K MT)
Global top five Inhalational Anesthesia Drugs companies in 2021 (%)
The global Inhalational Anesthesia Drugs market was valued at 1280.1 million in 2021 and is projected to reach US$ 1549.5 million by 2028, at a CAGR of 2.8% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Sevoflurane Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Inhalational Anesthesia Drugs include Baxter, AbbVie, Piramal Enterprises, Halocarbon Products, Jiangsu Hengrui Medicine and Fresenius Kabi, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Inhalational Anesthesia Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Inhalational Anesthesia Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Inhalational Anesthesia Drugs Market Segment Percentages, by Type, 2021 (%)
- Sevoflurane
- Desflurane
- Isoflurane
- Enflurane
Global Inhalational Anesthesia Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Inhalational Anesthesia Drugs Market Segment Percentages, by Application, 2021 (%)
- Hospitals
- Clinics
- Ambulatory Surgical Centers
Global Inhalational Anesthesia Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Inhalational Anesthesia Drugs Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Inhalational Anesthesia Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
- Key companies Inhalational Anesthesia Drugs revenues share in global market, 2021 (%)
- Key companies Inhalational Anesthesia Drugs sales in global market, 2017-2022 (Estimated), (K MT)
- Key companies Inhalational Anesthesia Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Baxter
- AbbVie
- Piramal Enterprises
- Halocarbon Products
- Jiangsu Hengrui Medicine
- Fresenius Kabi
